Literature DB >> 10726240

Catamenial epilepsy: in search of a clinical entity and its prevalence.

K J Weatherford1.   

Abstract

The prevalence of catamenial epilepsy has been difficult to determine for several reasons, including menstrual cycle variability and randomness of seizure occurrence, a high prevalence of seizure clustering in males and nonmenstruating females with epilepsy, and the lack of a definition of catamenial epilepsy in previous studies. Recently, a definition describing three distinct patterns that may provide a sensible nomenclature for future research on catamenial epilepsy has been proposed, and it may provide standardized criteria for inclusion in catamenial epilepsy studies. Such a definition should allow estimates of true prevalence of this disorder to be more precise and prospective treatment trials to be designed.

Entities:  

Mesh:

Year:  1999        PMID: 10726240     DOI: 10.1097/01376517-199912000-00002

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  4 in total

Review 1.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

2.  A rat model of epilepsy in women: a tool to study physiological interactions between endocrine systems and seizures.

Authors:  Helen E Scharfman; Gauri H Malthankar-Phatak; Daniel Friedman; Patrice Pearce; Daniel P McCloskey; Cynthia L Harden; Neil J Maclusky
Journal:  Endocrinology       Date:  2009-05-14       Impact factor: 4.736

3.  The relationship between menstrual disorders and education in women with intractable epilepsy.

Authors:  Mahdieh Afzali; Jafar Mehvari Habibabadi; Banafsheh Mohammadi; Sanaz Masoumi; Mahta Ranjbar; Masoumeh Cheshmavar; Seyed Navid Naghibi
Journal:  Am J Neurodegener Dis       Date:  2021-12-15

4.  Dehydroepiandrosterone (DHEA) Serum Levels Indicate Cerebrospinal Fluid Levels of DHEA and Estradiol (E2) in Women at Term Pregnancy.

Authors:  Pardes Habib; Joseph Neulen; Shahin Habib; Benjamin Rösing
Journal:  Reprod Sci       Date:  2021-03-26       Impact factor: 3.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.